PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

New biomarker to identify hepatitis B-infected patients at risk for liver cancer

Longer tips on chromosomes may be new noninvasive biomarker for hepatitis B patients, say Jefferson's Kimmel Cancer Center researchers

2012-04-04
(Press-News.org) CHICAGO— Hepatitis B-infected patients with significantly longer telomeres—the caps on the end of chromosomes that protect our genetic data— were found to have an increased risk of getting liver cancer compared to those with shorter ones, according to findings presented by researchers at Jefferson's Kimmel Cancer Center at the American Association for Cancer Research (AACR) Annual Meeting 2012.

The relative telomere length in hepatitis B-infected cases with liver cancer was about 50 percent longer than the telomere length of the cancer-free hepatitis B-infected controls.

A strong correlation between telomere length and non-cirrhotic hepatocellular carcinoma (HCC), a liver cancer commonly caused from hepatitis B and C viral infections, could help physicians better stratify the hepatitis B population in an effort to better prevent and treat the disease.

Previous reports have suggested telomere length plays a role in cancer prediction; however, there have been conflicting results and the majority of the studies measured telomere length in liver cells (hepatocytes) and white blood cells.

Here, Hushan Yang, Ph.D., of the Division of Population Science at the Department of Medical Oncology at Thomas Jefferson University and Jefferson's Kimmel Cancer Center, and colleagues used circulating cell-free serum DNA from an existing and ongoing clinical cohort at the Liver Disease Prevention Center at Thomas Jefferson University Hospital.

Tapping into a cohort of almost 2,600 Korean Americans, a population disproportionately infected with hepatitis B, the team analyzed blood samples from over 400 hepatitis B-infected patients to compare relative telomere length using quantitative real-time polymerase chain reaction (qRT-PCR).

This nested case-control study included 140 hepatitis B-HCC cases and 280 cancer-free hepatitis B controls. Demographic and clinical data were obtained for each patient through medical chart review and consulting with treating physicians.

All participants were restricted to Korean hepatitis B patients to control the confounding effects of ethnicity and HCC etiology. The large majority of the patients were infected at birth or childhood, making this population an ideal resource to study the long-term outcome of hepatitis B infection at the population level.

The hepatitis B-HCC cases were found to have a relative telomere length about 50 percent longer than the cancer-free controls (0.31 versus 0.20, P=0.003), a statistically significant difference.

The difference, however, was also only evident in males and in non-cirrhotic patients, and not cirrhotic patients, possibly because that the effect conferred by telomere length was overshadowed by the strong association between cirrhosis and HCC. There were also no statistical differences between cohorts with respect to age and smoking status.

"This is the first study to demonstrate that relative telomere length in circulating cell-free serum DNA could potentially be used as a simple, inexpensive and non- invasive biomarker for HCC risk," said Dr. Yang. "This sets the stage for further retrospective and prospective investigations, in-depth molecular characterizations, and other assessments to determine the clinical value of serum DNA telomere length in risk prediction and early detection of HCC."

INFORMATION:

Co-authors of the study were Shaogui Wan, Xiaoying Fu, Ronald Myers, Ph.D., Division of Population Science, Department of Medical Oncology, Thomas Jefferson University; Hie-Won Hann, M.D., Richard Hann, Jennifer Au, M.D., Division of Hepatology and Gastroenterology, Department of Medicine, Thomas Jefferson University; and Jinliang Xing, Department of Cell Biology, Fourth Military Medical University in China.

END



ELSE PRESS RELEASES FROM THIS DATE:

Mayo Clinic: Nutritional supplement works against some pancreatic cancer cells in mice

2012-04-04
ROCHESTER, Minn. -- The dietary supplement gamma-linoleic acid can inhibit the growth of a subset of pancreatic cancer cells and selectively promote cancer cell death in mice, a Mayo Clinic study has found. The supplement, a fatty acid also known as GLA, worked particularly well when combined with the chemotherapy drug gemcitabine, the researchers say. The findings were presented today by Mayo Clinic pathologist Ruth Lupu, Ph.D., at the American Association for Cancer Research (AACR) Annual Meeting 2012. "One of the most devastating facts about pancreatic cancer is the ...

Four New Sonic Games Available Now for Free at Sonic Games 365

2012-04-04
Sonic Games 365, a big player in the free gaming universe is now offering even more Adobe Flash games that incorporate beloved Sega characters such as Sonic, Tails, Knuckles, Amy and more. Sonic Games 365 has these added four brand new titles to its line-up: Sonic Spin Break, Sonic's Crazy Coin Collect, Sonic Rolling Ball, and Super Mario Save Sonic. These four games are all about promoting the true meaning of Sonic Games 365, which has been from day one to always have the largest selection of games featuring, feature everybody's favorite blue hedgehog, and never charge ...

Mayo Clinic study identifies optimal gene targets for new colon cancer test

2012-04-04
ROCHESTER, Minn. -- A study presented today by Mayo Clinic researchers at the American Association for Cancer Research (AACR) Annual Meeting 2012 in Chicago identified two genes that are optimal targets to be analyzed in a new noninvasive test for colorectal cancer developed by Mayo Clinic, in collaboration with Exact Sciences Corporation. The test uses a small sample of a patient's stool to check for specific DNA changes, known as gene methylation, that occur as cancer develops. The test can quickly detect both early stage cancer and precancerous polyps. "This study ...

Changes in asthma treatment improve wait time and patient care in Emergency

2012-04-04
OTTAWA, Canada -- Dr. Roger Zemek, Director of Emergency Research at the CHEO Research Institute and ED physician, and assistant professor in the Faculty of Medicine at the University of Ottawa, has overseen the creation and implementation of a Medical Directive that now empowers nurses to administer an oral steroid treatment, which has reduced wait time and improved patient care. This research is published today in Pediatrics. Asthma is the most common chronic illness in children requiring a visit to Emergency. Every year, the Children's Hospital of Eastern Ontario (CHEO) ...

New drug prevents spread of human prostate cancer cells

2012-04-04
CHICAGO --- A new drug developed by Northwestern Medicine scientists prevented human prostate cancer cells from spreading to other tissues without any toxic effects to normal cells or tissues. The drug turns off the "go" switch in the cancer cells and immobilizes them. Prostate cancer is the second-leading cause of cancer death in North American males. Death is mainly caused by metastasis, prostate cancer cells moving out of prostate tissue and spreading to other organs. "This is an extremely promising new therapeutic that locks down aggressive prostate cancer cells ...

Gladstone scientists find increased ApoE protein levels may promote Alzheimer's disease

2012-04-04
SAN FRANCISCO, CA—April 3, 2012—Scientists at the Gladstone Institutes have enhanced our understanding of how a protein linked to Alzheimer's disease keeps young brains healthy, but can damage them later in life—suggesting new research avenues for treating this devastating disease. In the Journal of Neuroscience, available online today, researchers in the laboratory of Yadong Huang, MD, PhD, have uncovered the distinct roles that the apoE protein plays in young vs. aging brains. These findings, which could inform the future of Alzheimer's drug development, come at a time ...

Pollen can protect mahogany from extinction

2012-04-04
New research from the University of Adelaide could help protect one of the world's most globally threatened tree species - the big leaf mahogany - from extinction. Big leaf mahogany (Swietenia macrophylla) is the most prized mahogany timber around the world. It is at risk of extinction in its native habitats because of the timber trade, particularly in Central and South America. To better understand how such a threatened species can be brought back from the brink of extinction, scientists from the University of Adelaide's Environment Institute have studied the important ...

Stomata development in plants unraveled -- a valuable discovery for environmental research

2012-04-04
Plants breathe through stomata Plant leaves are protected from drying out by an airtight wax layer. They breathe and release water through microscopic pores called stomata. Every year 40% of atmospheric CO2 and twice the volume of water found in our atmosphere pass through these pores. This means that stomata are not only important for plant development but also for our climate! It's no surprise then that these pores appear to be strictly regulated by plants. Stomata react extremely fast to internal plant signals and changes in the environment. When rain is scarce, ...

A study confirms that long commercials evoke stronger emotions

A study confirms that long commercials evoke stronger emotions
2012-04-04
What effect does a TV advert have on a viewer? How does it bring about a change in their knowledge, emotions or intentions? These questions have existed alongside advertising ever since it began. Through a psycho-physiological study developed jointly by El Bureau de la Comunicación, the Tecnalia Centre for Applied Research, and the UPV/EHU, it has been possible to measure the emotional response of a person to a series of television adverts. The aim of the study, carried out for the first time entirely in the Basque Autonomous Community (region), was to shed some light ...

Viral replication impedes the efficacy of a targeted therapy against virus-induced lymphomas

2012-04-04
Kaposi's sarcoma herpesvirus (KSHV) is a human tumor virus and an etiological agent for Kaposi's sarcoma and primary effusion lymphoma (PEL). PELs are aggressive lymphomas with reported median survival time shorter than six months after diagnosis. Researchers at the University of Helsinki discovered that spontaneous induction of KSHV lytic replication in tumors drastically attenuated the p53-dependent apoptotic response not only to a targeted therapy (Nutlin-3) but also to genotoxic anti-cancer agents. The findings by the research groups of Päivi Ojala (Institute of ...

LAST 30 PRESS RELEASES:

NCCN Summit seeks to improve care for veterans and first responders with cancer from line-of-duty exposure

ERC Consolidator Grant for soft robotics researcher

Dual-action arts and wellbeing program transforms dementia care

The global plastic waste trade contributes to coastal litter in importing countries, study shows

UT Dallas partners with Tech Mahindra on AI innovation

Blinking less could signal the brain is working harder to listen, Concordia study shows

Male bonobos track females’ reproductive cycle to maximize mating success

New report outlines science priorities for human Mars exploration

Want to curb cannabis-related crashes? Don’t forget older adults, study finds

Expectant management vs medication for patent ductus arteriosus in preterm infants

Pew funds 7 new biomedical research collaborations

The ERC selects 349 mid-career researchers for €728 million in Consolidator Grants

ERC Consolidator Grant awarded to CISPA researcher Rayna Dimitrova

Antimicrobial effects of Syzygium aromaticum and Salvadora persica against common peri-implantitis pathogens in vitro

EVs pose no greater risk to pedestrians than conventional vehicles

Modeling microplastic accumulation under the ocean surface

Pompeii offers insights into ancient Roman building technology

University of Utah engineers give a bionic hand a mind of its own

Transient and long-term risks of common physical activities in people with low back pain

Health care contact days in older adults with metastatic cancer

Brain resilience science reshapes psychiatry from treating illness to building strength

An assessment of the antidepressant potential of deramciclane in two animal tests

Pitt and UPMC study finds epigenetic signature of pediatric traumatic brain injury, paves way for precision recovery tools

Brain discovery opens door to earlier detection of metabolic syndrome in women

SwRI-led study provides insight into oscillations in solar flares

Announcing the third cohort of the Hevolution/AFAR new investigator awards in aging biology and geroscience research

GeoFlame VISION: Using AI and satellite imagery to predict future wildfire risk

Nationwide study suggests that water treatment methods may impact the risk of legionnaires’ disease

Oyster larvae on drugs move slowly and are stressed

Targeting a specific brain circuit may help prevent opioid relapse, WSU study finds

[Press-News.org] New biomarker to identify hepatitis B-infected patients at risk for liver cancer
Longer tips on chromosomes may be new noninvasive biomarker for hepatitis B patients, say Jefferson's Kimmel Cancer Center researchers